Literature DB >> 24997082

Simultaneous occurrence of medullary and differentiated thyroid carcinomas. Report of 4 cases and brief review of the literature.

Seval Erhamamci1, Mehmet Reyhan, Nazim Emrah Kocer, Gül Nihal Nursal, Neşe Torun, Ali Fuat Yapar.   

Abstract

Simultaneous occurrence of medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC) in a single patient is an unusual event. The incidence, cell origin, histopathology features and prognosis of these two carcinomas are considered completely different. The aim of this retrospective study was to describe clinical, pathologic characteristics and the prevalence of diagnosing such patients in our clinic. Between October 2003 and December 2013, 1.420 consecutive patients diagnosed by histology as having differentiated thyroid carcinoma (DTC) and treated with radioactive iodide (RAI) were retrospectively investigated. Of these, 4 patients were diagnosed by histology as having simultaneous MTC and PTC. The clinical and pathology characteristics of these patients are described. The prevalence of simultaneous MTC and PTC of these 4 patients in our clinic was 0.28% of all patients with DTC. The age of the 4 patients ranged from 44 to 63 years and were three females and one male. These patients are currently alive without disease from either of the two types of cancer. In two of these patients, MTC was located in the left and PTC in the right thyroid lobe. One patient had MTC in the right lobe and PTC in both lobes. The remaining patient had both cancers in the left lobe as a mixed tumor. We are able to present the pathology of only 2 of these 4 patients. In these 2 patients MTC was located in the left and PTC in the right thyroid lobe, one of them was female and the other was male, aged 44 and 49, respectively. In conclusion, our results suggested that simultaneous occurrence of MTC and PTC had a prevalence in our clinic of 0.28% among 1420 consecutive patients with DTC or 0.14%, if only the 2 patients in whom we are able to present their pathology slides are considered. Our cases suggest that these two tumors are usually independent and coincidental events in every patient.

Entities:  

Mesh:

Year:  2014        PMID: 24997082     DOI: 10.1967/s002449910137

Source DB:  PubMed          Journal:  Hell J Nucl Med        ISSN: 1790-5427            Impact factor:   1.102


  6 in total

1.  Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

Authors:  R Ciampi; C Romei; L Pieruzzi; A Tacito; E Molinaro; L Agate; V Bottici; F Casella; C Ugolini; G Materazzi; F Basolo; R Elisei
Journal:  J Endocrinol Invest       Date:  2016-08-17       Impact factor: 4.256

2.  Heterogeneous Periostin Expression in Different Histological Variants of Papillary Thyroid Carcinoma.

Authors:  Simona Eliza Giusca; Cornelia Amalinei; Ludmila Lozneanu; Delia Ciobanu Apostol; Elena Corina Andriescu; Alex Scripcariu; Raluca Balan; Elena Roxana Avadanei; Irina-Draga Căruntu
Journal:  Biomed Res Int       Date:  2017-12-25       Impact factor: 3.411

3.  Epidemiology of Simultaneous Medullary and Papillary Thyroid Carcinomas (MTC/PTC): An Italian Multicenter Study.

Authors:  Marialuisa Appetecchia; Rosa Lauretta; Agnese Barnabei; Letizia Pieruzzi; Irene Terrenato; Elisabetta Cavedon; Caterina Mian; Maria Grazia Castagna; Rossella Elisei
Journal:  Cancers (Basel)       Date:  2019-10-09       Impact factor: 6.639

4.  Simultaneous Occurrence of Papillary Carcinoma and Medullary Carcinoma.

Authors:  Lyza Camille Gadong; Thelma Crisostomo
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-11-09

5.  Mixed medullary-papillary thyroid carcinoma with mixed lymph node metastases: A case report.

Authors:  Vanessa Guerreiro; Cláudia Costa; Joana Oliveira; Ana Paula Santos; Mónica Farinha; Manuel Jácome; Paula Freitas; Davide Carvalho; Isabel Torres
Journal:  Clin Case Rep       Date:  2021-05-24

6.  Intermixed medullary and papillary thyroid cancer in a patient with renal cell carcinoma.

Authors:  Shanika Samarasinghe; Simge Yuksel; Swati Mehrotra
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.